Nanomaterials in tuberculosis DNA vaccine delivery: historical perspective and current landscape
Open Access
- 8 September 2022
- journal article
- research article
- Published by Taylor & Francis in Drug Delivery
- Vol. 29 (1) , 2912-2924
Abstract
Vaccinations, especially DNA vaccines that promote host immunity, are the most effective interventions for tuberculosis (TB) control. However, the vaccine delivery system exhibits a significant impact on the protective effects of the vaccine. Recently, effective nanomaterial-based delivery systems (including nanoparticles, nanogold, nanoliposomes, virus-like particles, and virus carriers) have been developed for DNA vaccines to control TB. This review highlights the historical development of various nanomaterial-based delivery systems for TB DNA vaccines, along with the emerging technologies. Nanomaterial-based vaccine delivery systems could enhance the efficacy of TB vaccination; therefore, this summary could guide nanomaterial selection for optimal and safe vaccine delivery, facilitating the design and development of highly effective TB vaccines.Keywords
Funding Information
- Natural Science Foundation of Hainan Province (2019JJ40321)
- Scientific Research Project of Hunan Provincial Health Commission (20201933)
- National Natural Science Foundation of China (32000651)
- National Natural Science Foundation of China (31670938)
- National Natural Science Foundation of China (32070924)
- Natural Science Foundation Project Program of Chongqing (2019jcyjA-msxmx0159)
- Natural Science Foundation Project Program of Chongqing (2014jcyjA0107)
This publication has 109 references indexed in Scilit:
- Utilization of biodegradable polymeric materials as delivery agents in dermatologyClinical, Cosmetic and Investigational Dermatology, 2014
- Pre-existing immunity against vaccine vectors – friend or foe?Microbiology, 2013
- Mycobacterium vaccae as Adjuvant Therapy to Anti-Tuberculosis Chemotherapy in Never-Treated Tuberculosis Patients: A Meta-AnalysisPLOS ONE, 2011
- DNA Vaccine Constructs Expressing Mycobacterium tuberculosis-Specific Genes Induce Immune ResponsesScandinavian Journal of Immunology, 2010
- DNA vaccines: ready for prime time?Nature Reviews Genetics, 2008
- Adjuvant modulation of the cytokine balance in Mycobacterium tuberculosis subunit vaccines; immunity, pathology and protectionImmunology, 2008
- Improve protective efficacy of a TB DNA-HSP65 vaccine by BCG primingGenetic Vaccines and Therapy, 2007
- Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectivenessThe Lancet, 2006
- Effect of different adjuvants on the immune responses of cattle vaccinated with Mycobacterium tuberculosis culture filtrate proteinsVeterinary Immunology and Immunopathology, 2002
- DDA as an immunological adjuvantResearch in Immunology, 1992